- •There is a lack of prospective level I evidence for the use of PBT for most adult cancers including oropharyngeal squamous cell carcinoma (OPSCC).
- •TORPEdO is the UK’s first PBT clinical trial and aims to determine the benefits of PBT for OPSCC.
- •Training and support has been provided before and during the trial to reduce variations of contouring and radiotherapy planning.
- •There is a strong translational component within TORPEdO. Imaging and physics data along with blood, tissue collection will inform future studies in refining patient selection for IMPT.
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Clinical and Translational Radiation Oncology
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin. 2021; 71: 209-249
Mehanna H, Evans M, Beasley M, Chatterjee S, Dilkes M, et al. Oropharyngeal cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016 May;130(S2):S90-S96.
- at al Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.Lancet Oncol. 2011 Feb; 12: 127-136
- TORPEdO - A Phase III Trial of Intensity-modulated Proton Beam Therapy Versus Intensity-modulated Radiotherapy for Multi-toxicity Reduction in Oropharyngeal Cancer.Clin Oncol (R Coll Radiol). 2020 Feb; 32: 84-88
National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group (CTRad) Proton Beam Clinical Trial Strategy Group. Proton Beam Therapy – the Challenges of Delivering High-quality Evidence of Clinical Benefit. Clin Oncol (R Coll Radiol). 2018 May;30(5):280-284.
- Systematic review of methodology used in clinical studies evaluating the benefits of proton beam therapy.Clin Transl Radiat Oncol. 2019 Jul; 12: 17-26
- Too Big to Fail? The Current Status of Proton Therapy in the USA.Clin Oncol (R Coll Radiol). 2018 May; 30: 271-273
- The Road Map for National Health Service Proton Beam Therapy.Clin Oncol (R Coll Radiol). 2018 May; 30: 277-279
- Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy.J Clin Oncol. 2008 Aug 1; 26: 3770-3776
- The clinical application of the 100mL water swallow test in head and neck cancer.Oral Oncol. 2011 Mar; 47: 180-184
- A performance status scale for head and neck cancer patients.Cancer. 1990 Aug 1; 66: 564-569
- Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis.Radiother Oncol. 2016 Jul; 120: 48-55
- Prognostic factors for tube feeding dependence after curative (chemo-) radiation in head and neck cancer: A systematic review of literature.Radiother Oncol. 2018 Jan; 126: 56-67
Mehta S, Kent Y, McPartlin A, Garcez K, Sykes A et al. Feeding tube dependency at 12 months post treatment in oropharyngeal cancer patient treated with radical intent- a single institute experience. Eur J Surg Oncol. 2018; Volume 44(Supplement 1): S45-S46.
- Patient-reported outcomes following parotid-sparing intensity-modulated radiotherapy for head and neck cancer. How important is dysphagia?.Oral Oncol. 2014 Dec; 50: 1182-1187
- Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach.Radiother Oncol. 2013 Jun; 107: 267-273
Rwigema JC, Langendijk JA, van der Laan HP, Lukens JN, Swisher-McClure SD, et al. Proton Therapy Improves Toxicity for Oropharyngeal Cancer: An Outcomes and Predictive Model-based Approach, International Journal of Radiation Oncology*Biology*Physics, Volume 99, Issue 2, Supplement, 2017, Pages S135-S136.
- A Comparative Study of Patient-Reported Xerostomia and Dysgeusia in Oropharyngeal Squamous Cell Carcinoma (OPSCC) Treated With Volumetric Modulated Arc Therapy (VMAT) or Proton Pencil Beam Scanning (PBS).International Journal of Radiation Oncology*Biology*Physics, Volume 93, Issue. 2015; 3: S69-S70
Sharma S, Zhou O, Thompson RF, Lukens JN, Lin A, et al. Correlation of Dosimetric Parameters to Patient-Reported Taste Changes After Radiation for Oropharyngeal Squamous Cell Carcinoma, International Journal of Radiation Oncology*Biology*Physics, Volume 96, Issue 2, Supplement, 2016, Page E354.
Nutting C, Rooney K, Foran B, Pettit L, Beasley M, et al. Results of a randomized phase III study of dysphagia-optimized intensity modulated radiotherapy (Do-IMRT) versus standard IMRT (S-IMRT) in head and neck cancer. Journal of Clinical Oncology 2020 38:15_suppl, 6508-6508.
User LicenseCreative Commons Attribution (CC BY 4.0) |
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article
- Reuse portions or extracts from the article in other works
- Sell or re-use for commercial purposes
Elsevier's open access license policy